What i would like to know is of the $1M they get, exactly how much of this will be spent on the experiment and how much of it will go towards the Diamonds wage and other under disclosed (cough, cough) "office admin" fees.
The Diamond needs to chip in here by way of taking a pay cut allowing funds to last longer and more of the money to be spent on what it should be spent on.
- Forums
- ASX - By Stock
- PER
- News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review
News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-35
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $83.97M |
Open | High | Low | Value | Volume |
8.0¢ | 8.1¢ | 8.0¢ | $61.91K | 766.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 549730 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.1¢ | 94626 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 549730 | 0.080 |
10 | 905447 | 0.079 |
15 | 693681 | 0.078 |
10 | 975506 | 0.077 |
8 | 884271 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.081 | 94626 | 1 |
0.082 | 150000 | 1 |
0.083 | 25000 | 1 |
0.084 | 200000 | 1 |
0.086 | 250000 | 1 |
Last trade - 15.59pm 31/10/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |